Paul Peloso - 09 May 2023 Form 4 Insider Report for ACELYRIN, Inc. (SLRN)

Role
Chief Medical Officer
Signature
/s/ Mina Kim, Attorney-in-fact
Issuer symbol
SLRN
Transactions as of
09 May 2023
Net transactions value
+$108,000
Form type
4
Filing time
11 May 2023, 20:54:15 UTC
Previous filing
04 May 2023
Next filing
18 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRN Common Stock Purchase $108,000 +6,000 $18.00 6,000 09 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLRN Employee Stock Option (right to buy) Other $0 -173,681 -100% $0.000000* 0 09 May 2023 Class A Common Stock 173,681 $0.7683 Direct F2, F3
transaction SLRN Employee Stock Option (right to buy) Other $0 +173,681 $0.000000 173,681 09 May 2023 Common Stock 173,681 $0.7683 Direct F2, F3
transaction SLRN Employee Stock Option (right to buy) Other $0 -156,500 -100% $0.000000* 0 09 May 2023 Class A Common Stock 156,500 $4.04 Direct F2, F4
transaction SLRN Employee Stock Option (right to buy) Other $0 +156,500 $0.000000 156,500 09 May 2023 Common Stock 156,500 $4.04 Direct F2, F4
transaction SLRN Employee Stock Option (right to buy) Other $0 -187,988 -100% $0.000000* 0 09 May 2023 Class A Common Stock 187,988 $5.88 Direct F2, F5
transaction SLRN Employee Stock Option (right to buy) Other $0 +187,988 $0.000000 187,988 09 May 2023 Common Stock 187,988 $5.88 Direct F2, F5
transaction SLRN Employee Stock Option (right to buy) Other $0 -154,957 -100% $0.000000* 0 09 May 2023 Class A Common Stock 154,957 $18.00 Direct F2, F6
transaction SLRN Employee Stock Option (right to buy) Other $0 +154,957 $0.000000 154,957 09 May 2023 Common Stock 154,957 $18.00 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares purchased through a directed share program in the Issuer's initial public offering of Common Stock (the "IPO").
F2 Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the IPO.
F3 1/4 of the shares subject to the option vested on May 16, 2022 and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service.
F4 1/4 of the shares subject to the option vested on January 20, 2023, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service.
F5 1/4 of the shares subject to the option vest on November 17, 2023, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service.
F6 1/4 of the shares subject to the option vest on May 4, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service.